dc.contributor.author | Ozturk, Z | |
dc.contributor.author | Kokoglu, E | |
dc.contributor.author | Ekmekci, H | |
dc.contributor.author | Baloglu, H | |
dc.contributor.author | Sonmez, H | |
dc.date.accessioned | 2021-03-03T10:49:41Z | |
dc.date.available | 2021-03-03T10:49:41Z | |
dc.date.issued | 2003 | |
dc.identifier.citation | Sonmez H., Ozturk Z., Ekmekci H., Baloglu H., Kokoglu E., "TBARS, carnitine, and reduced glutathione levels in human bladder carcinoma", BIOCHEMISTRY-MOSCOW, cilt.68, sa.3, ss.346-348, 2003 | |
dc.identifier.issn | 0006-2979 | |
dc.identifier.other | av_24cb2921-c952-416f-96f0-159f758ad0c2 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/29623 | |
dc.identifier.uri | https://doi.org/10.1023/a:1023018620047 | |
dc.description.abstract | In this study, we investigated tissue levels of reduced glutathione (GSH) and carnitine as well as thiobarbituric acid reactive substances (TBARS. as a marker of lipid peroxidation) levels in bladder carcinoma and control group of patients. The average GSH, carnitine and TBARS levels for tumor group were respectively 7.11 +/- 3.3 mug/mg protein, 1.81 +/- 0.39 nmol/mg protein, and 4.29 +/- 3.2 mumol/mg protein, versus 14.45 +/- 4.11 mug/mg protein, 2.14 +/- 0.66 nmol/mg protein, and 2.3 +/- 0.6 mumol/mg protein for normal bladder tissues. Thus, tissue reduced glutathione levels (GSH) were significantly lower in patients as compared with the control group (p 0.05). | |
dc.language.iso | eng | |
dc.subject | Temel Bilimler | |
dc.subject | Sitogenetik | |
dc.subject | Moleküler Biyoloji ve Genetik | |
dc.subject | Yaşam Bilimleri | |
dc.subject | Yaşam Bilimleri (LIFE) | |
dc.subject | Moleküler Biyoloji ve Genetik | |
dc.subject | BİYOKİMYA VE MOLEKÜLER BİYOLOJİ | |
dc.title | TBARS, carnitine, and reduced glutathione levels in human bladder carcinoma | |
dc.type | Makale | |
dc.relation.journal | BIOCHEMISTRY-MOSCOW | |
dc.contributor.department | , , | |
dc.identifier.volume | 68 | |
dc.identifier.issue | 3 | |
dc.identifier.startpage | 346 | |
dc.identifier.endpage | 348 | |
dc.contributor.firstauthorID | 167846 | |